The Enterprise Value as of December 2024 (TTM) for Abeona Therapeutics Inc. (ABEO) is 254.30M

According to Abeona Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 254.30M. This represents a change of 26.60% compared to the average of 200.87M of the last 4 quarters.

Abeona Therapeutics Inc. (ABEO) Historical Enterprise Value (quarterly & annually)

How has ABEO Enterprise Value performed in the past?

The mean historical Enterprise Value of Abeona Therapeutics Inc. over the last ten years is 133.21M. The current 254.30M Enterprise Value has changed 18.99% with respect to the historical average. Over the past ten years (40 quarters), ABEO's Enterprise Value was at its highest in in the June 2018 quarter at 706.87M. The Enterprise Value was at its lowest in in the December 2021 quarter at 12.04M.

Abeona Therapeutics Inc. (ABEO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Abeona Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Abeona Therapeutics Inc. (ABEO) Average Enterprise Value

How has ABEO Enterprise Value performed in the past?

The current Enterprise Value of Abeona Therapeutics Inc. (ABEO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Abeona Therapeutics Inc. (ABEO) Enterprise Value vs. Peers

How is ABEO’s Enterprise Value compared to its peers?

Abeona Therapeutics Inc.’s Enterprise Value is greater than Reviva Pharmaceuticals Holdings, Inc. (77.44M), greater than Athira Pharma, Inc. (-46583348.00), greater than Fortress Biotech, Inc. (62.64M), less than ACADIA Pharmaceuticals Inc. (2.73B), greater than Cabaletta Bio, Inc. (-41011352.00), less than Calithera Biosciences, Inc. (0), greater than Affimed N.V. (-23784513.00), greater than Checkpoint Therapeutics, Inc. (23.59M), greater than Adaptimmune Therapeutics plc (170.50M), greater than Mereo BioPharma Group plc (55.99M), less than Pieris Pharmaceuticals, Inc. (510.15M), greater than PDS Biotechnology Corporation (-1407736.00), greater than Leap Therapeutics, Inc. (36.27M), greater than X4 Pharmaceuticals, Inc. (49.06M), greater than Terns Pharmaceuticals, Inc. (79.71M), greater than Day One Biopharmaceuticals, Inc. (223.81M), less than Inozyme Pharma, Inc. (857.57M), greater than REGENXBIO Inc. (210.44M), less than Anebulo Pharmaceuticals, Inc. (394.08M), greater than Invivyd, Inc. (40.61M), greater than Black Diamond Therapeutics, Inc. (-44243802.00), greater than null (123.50M),

Build a custom stock screener for Abeona Therapeutics Inc. (ABEO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abeona Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Abeona Therapeutics Inc. (ABEO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Abeona Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.